Cargando…

Human Placental Mesenchymal Stem Cells Relieve Primary Sclerosing Cholangitis via Upregulation of TGR5 in Mdr2(−/−) Mice and Human Intrahepatic Cholangiocyte Organoid Models

Primary sclerosing cholangitis (PSC) is a biliary disease accompanied by chronic inflammation of the liver and biliary stricture. Mesenchymal stem cells (MSCs) are used to treat liver diseases because of their immune regulation and regeneration-promoting functions. This study was performed to explor...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yao, Qigu, Chen, Wenyi, Yu, Yingduo, Gao, Feiqiong, Zhou, Jiahang, Wu, Jian, Pan, Qiaoling, Yang, Jinfeng, Zhou, Lingling, Yu, Jiong, Cao, Hongcui, Li, Lanjuan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AAAS 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10433880/ https://www.ncbi.nlm.nih.gov/pubmed/37600495 http://dx.doi.org/10.34133/research.0207

Ejemplares similares

Highly Efficient Methods to Culture Mouse Cholangiocytes and Small Intestine Organoids
por: Chen, Wenyi, et al.
Publicado: (2022)

Knockdown of vimentin reduces mesenchymal phenotype of cholangiocytes in the Mdr2(−/−) mouse model of primary sclerosing cholangitis (PSC)
por: Zhou, Tianhao, et al.
Publicado: (2019)

Cholangiocytes and the environment in primary sclerosing cholangitis: where is the link?
por: O’Hara, Steven P, et al.
Publicado: (2017)

Cholangiocyte senescence in primary sclerosing cholangitis is associated with disease severity and prognosis
por: Cazzagon, Nora, et al.
Publicado: (2021)

Characterization of cultured cholangiocytes isolated from livers of patients with primary sclerosing cholangitis
por: Tabibian, James H., et al.
Publicado: (2014)

Telomere dysfunction promotes cholangiocyte senescence and biliary fibrosis in primary sclerosing cholangitis
por: Jalan-Sakrikar, Nidhi, et al.
Publicado: (2023)

Mutational Characterization of the Bile Acid Receptor TGR5 in Primary Sclerosing Cholangitis
por: Hov, Johannes R., et al.
Publicado: (2010)

Development and Characterization of Cholangioids from Normal and Diseased Human Cholangiocytes as an In Vitro Model to Study Primary Sclerosing Cholangitis
por: Loarca, Lorena, et al.
Publicado: (2017)

Mesenchymal stem cells protect against ferroptosis via exosome-mediated stabilization of SLC7A11 in acute liver injury
por: Lin, Feiyan, et al.
Publicado: (2022)

Stem cell therapy for Crohn’s disease: systematic review and meta-analysis of preclinical and clinical studies
por: Wang , Ruo, et al.
Publicado: (2021)

Recent discoveries in microbiota dysbiosis, cholangiocytic factors, and models for studying the pathogenesis of primary sclerosing cholangitis
por: Huang, Yu, et al.
Publicado: (2022)

Characteristic Analysis of Featured Genes Associated with Cholangiocarcinoma Progression
por: Yao, Qigu, et al.
Publicado: (2023)

Mesenchymal stem cells shift the pro-inflammatory phenotype of neutrophils to ameliorate acute lung injury
por: Feng, Bing, et al.
Publicado: (2023)

Pooled Analysis of Mesenchymal Stromal Cell-Derived Extracellular Vesicle Therapy for Liver Disease in Preclinical Models
por: Fang, Xinru, et al.
Publicado: (2023)

Secondary sclerosing cholangitis: mimics of primary sclerosing cholangitis
por: Ludwig, Daniel R., et al.
Publicado: (2022)

Ursodeoxycholate inhibits mast cell activation and reverses biliary injury and fibrosis in Mdr2(−/−) mice and human primary sclerosing cholangitis
por: Meng, Fanyin, et al.
Publicado: (2018)

Administration of Human MSC-Derived Extracellular Vesicles for the Treatment of Primary Sclerosing Cholangitis: Preclinical Data in MDR2 Knockout Mice
por: Angioni, Roberta, et al.
Publicado: (2020)

Hypoxia-inducible factor-2 alpha promotes the proliferation of human placenta-derived mesenchymal stem cells through the MAPK/ERK signaling pathway
por: Zhu, Chengxing, et al.
Publicado: (2016)

IgG4-Related Sclerosing Cholangitis and Primary Sclerosing Cholangitis
por: Tanaka, Atsushi
Publicado: (2019)

Engineered fibroblast growth factor 19 reduces liver injury and resolves sclerosing cholangitis in Mdr2‐deficient mice
por: Zhou, Mei, et al.
Publicado: (2016)

Human β-Defensin 2 in Primary Sclerosing Cholangitis
por: Chang, Cindy, et al.
Publicado: (2017)

Primary sclerosing cholangitis.
por: Spence, R. A., et al.
Publicado: (1984)

Primary sclerosing cholangitis
por: Worthington, Joy, et al.
Publicado: (2006)

Efficacy and Safety of Treatments for Patients With Portal Hypertension and Cirrhosis: A Systematic Review and Bayesian Network Meta-Analysis
por: Yao, Qigu, et al.
Publicado: (2021)

FGF1 Signaling Modulates Biliary Injury and Liver Fibrosis in the Mdr2(−/−) Mouse Model of Primary Sclerosing Cholangitis
por: O’Brien, April, et al.
Publicado: (2022)

Human placenta mesenchymal stem cell-derived exosomes delay H(2)O(2)-induced aging in mouse cholangioids
por: Chen, Wenyi, et al.
Publicado: (2021)

Unique DUOX2(+)ACE2(+) small cholangiocytes are pathogenic targets for primary biliary cholangitis
por: Li, Xi, et al.
Publicado: (2023)

The immunobiology of primary sclerosing cholangitis
por: Aron, Jonathan H., et al.
Publicado: (2009)

Pathogenesis of primary sclerosing cholangitis
por: Pollheimer, Marion J., et al.
Publicado: (2011)

Primary sclerosing cholangitis and pregnancy
por: Kammeijer, Casper Q., et al.
Publicado: (2011)

Sclerosing Cholangitis in Behçet's Disease
por: Ben Slama Trabelsi, Aida, et al.
Publicado: (2013)

An Overview on Primary Sclerosing Cholangitis
por: Vlăduţ, Cătălina, et al.
Publicado: (2020)

Non-steroidal FXR agonist cilofexor improves cholestatic liver injury in the Mdr2(-/-) mouse model of sclerosing cholangitis
por: Fuchs, Claudia D., et al.
Publicado: (2023)

Genetic or pharmacological reduction of cholangiocyte senescence improves inflammation and fibrosis in the Mdr2(-/-) mouse
por: Alsuraih, Mohammed, et al.
Publicado: (2021)

Diagnostic and Prognostic Roles of Thrombospondin-2 in Digestive System Cancers
por: Gao, Feiqiong, et al.
Publicado: (2022)

Long-Term Follow-Up into Adulthood of Pediatric-Onset Primary Sclerosing Cholangitis and Autoimmune Sclerosing Cholangitis
por: Hercun, Julian, et al.
Publicado: (2022)

Secondary sclerosing cholangitis and IgG4-sclerosing cholangitis – A review of cholangiographic and ultrasound imaging
por: Möller, Kathleen, et al.
Publicado: (2022)

Secondary Sclerosing Cholangitis and Hodgkin’s Lymphoma
por: Abedi, Seyed Hassan, et al.
Publicado: (2015)

Secondary Sclerosing Cholangitis During Pregnancy
por: Abdulqader, Yasir, et al.
Publicado: (2016)

Treatment of primary sclerosing cholangitis in children
por: Laborda, Trevor J, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_rf2qrr29i250i7mrbcih9vpt0e